• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » 10-year data shows sustained pain relief with Accuray’s CyberKnife system

10-year data shows sustained pain relief with Accuray’s CyberKnife system

March 31, 2022 By Sean Whooley

Accuray CyberKnife S7
CyberKnife S7 system (Image from Accuray)

Accuray (NSDQ:ARAY) announced today that long-term follow-up data demonstrated pain relief after image-guided robotic radiosurgery treatments with its CyberKnife system.

The data from a study of men and women with trigeminal neuralgia (TN) showed that 72% continued to experience pain relief 10 years after receiving the treatments delivered with the CyberKnife system.

“Robotic Image-Guided Radiosurgery for Trigeminal Neuralgia: Results after 10 Years,” the study abstract, was recognized as “Best Clinical Abstract” at the recent 2022 Radiosurgical Society Meeting in Carlsbad, California, according to a news release.

Sunnyvale, California-based Accuray designed the CyberKnife system to treat diseases in the head and base of the skull, as well as functional disorders, with radiosurgery, but without the use of a fixed frame bolted to the patient’s head.

The company said the system features a linear accelerator (linac) directly mounted on a robot that moves and bends around the patient to deliver non-isocentric, non-coplanar radiation beams from potentially thousands of unique angles. Using advanced imaging and Accuray-exclusive Synchrony real-time target tracking with dynamic delivery technology, Accuray said CyberKnife can track a tumor or lesion and continuously verify its position, automatically correcting and adapting the radiation beam position for the slightest of movements.

Synchrony uses advanced algorithms and AI to account for motion with uninterrupted delivery. With this design, Accuray said the CyberKnife delivers precise and accurate treatments in typically just one to five visits.

“Clinical data continues to confirm the durable benefits that CyberKnife radiosurgery can provide over the long term. The system delivers advanced radiotherapy treatments with sub-millimeter accuracy, which is of critical importance when treating tumors and lesions in the brain while minimizing risk of potential side effects,” Accuray President Suzanne Winter said in the release. “This most recent trigeminal neuralgia study reinforces why medical care teams turn to CyberKnife radiosurgery when precision and accuracy are essential and demonstrates the positive impact this non-invasive treatment option may have on the lives of people living with this severe and challenging-to-treat medical condition.”

Filed Under: Clinical Trials, Featured, Imaging, Oncology Tagged With: Accuray Inc.

More recent news

  • Zimmer Biomet, Think Surgical extend exclusive distribution agreement
  • Cambridge Heartwear inks £184M deal to supply NHS with portable ECG monitors
  • J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
  • California and Massachusetts still reign as top US medtech headquarters locations
  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy